• 20-HETE Drives TRPV1-Dependent Itch in Chronic Dermatitis Mo

  2026-07-17

  This study reveals that elevated 20-HETE in chronic dermatitis activates TRPV1 channels on MrgprA3+ sensory neurons, inducing allokinetic itch and pain behaviors. These findings clarify sensory cross-talk in chronic skin inflammation and identify the 20-HETE–TRPV1–MrgprA3+ axis as a promising therapeutic target.

• Plant Extracts as Molluscicides: Hagenia abyssinica’s Potenc

  2026-07-16

  This study rigorously evaluates the molluscicidal activity of Hagenia abyssinica, Rosa abyssinica, and Cucumis ficifolius extracts against Biomphalaria and Bulinus snails—key vectors for schistosomiasis transmission in Ethiopia. The findings highlight the exceptional efficacy and safety profile of H. abyssinica flower extracts, supporting their further development as plant-based snail control agents.

• Panobinostat (LBH589): Next-Gen HDACi for Cancer Stress Path

  2026-07-16

  Explore how Panobinostat (LBH589) reshapes apoptosis and proteotoxic stress in cancer cells. This article provides advanced scientific insights and protocol guidance, setting it apart from conventional HDAC inhibitor content.

• MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu

  2026-07-15

  Unlock the full potential of MTT with advanced workflow enhancements, troubleshooting insights, and practical guidance on metabolic activity measurement in complex in vitro models. Leverage high-purity MTT from APExBIO for robust, reproducible cell viability and cytotoxicity data, even in challenging assay formats.

• Poly(I:C): dsRNA Analog Illuminates Cardiac Innate Immunity

  2026-07-15

  Explore the unique role of Poly(I:C), a synthetic double-stranded RNA analog, in dissecting innate immune responses within cardiomyocytes. This article unveils new mechanistic insights and assay strategies, contrasting standard immunology approaches.

• Primidone and Other AEDs: Inhibition of Human Serum Paraoxon

  2026-07-14

  This study systematically investigates the in vitro inhibitory effects of several antiepileptic drugs (AEDs), including Primidone (Mysoline), on human serum paraoxonase-1 (hPON1), an enzyme crucial for HDL function and oxidative stress regulation. The findings reveal distinct, noncompetitive inhibition profiles for each AED, offering new insights into their metabolic interactions and potential cardiovascular implications.

• Prostaglandin E2: Optimizing Inflammation & Immunity Workflo

  2026-07-14

  Harness the multifaceted power of Prostaglandin E2 (PGE2) in experimental setups targeting inflammation, immune modulation, and gastrointestinal protection. This guide translates emerging insights and expert protocols into actionable, reproducible steps for advanced cell-based and translational research.

• ECL Western Blotting Substrate: Technical Use and Workflow G

  2026-07-13

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of horseradish peroxidase (HRP) in chemiluminescent Western blot assays. It is optimal for molecular biology, cancer biology, and signal transduction pathway protein analysis, but should not be used in protocols requiring fluorescent or radioisotopic detection.

• Indazole/Indole-Based Glucagon Receptor Antagonists: Synthes

  2026-07-13

  This study introduces a structurally novel series of indazole- and indole-based glucagon receptor antagonists as potential therapies for type 2 diabetes. The research advances synthetic methodology, explores detailed structure–activity relationships, and yields potent compounds with robust in vitro and in vivo profiles for glycemic control.

• Thioredoxin System Modulates Chk1 Inhibitor Sensitivity in N

  2026-07-12

  This study uncovers how the thioredoxin (Trx) system regulates sensitivity to Chk1 inhibitors in non-small cell lung cancer (NSCLC) by modulating ribonucleotide reductase and deoxynucleotide pools. The findings highlight a redox-dependent mechanism that could be exploited to enhance Chk1 inhibitor efficacy while addressing toxicity challenges in clinical translation.

• Alosetron in GI Research: Unveiling 5-HT3 Antagonist Impact

  2026-07-10

  Explore how Alosetron, a selective 5-HT3 receptor antagonist, uniquely advances understanding of gastrointestinal stem cell fate and polarity. This article provides a deep dive into molecular mechanisms, protocol insights, and the latest research breakthroughs for sophisticated GI assays.

• Docetaxel in Translational Oncology: Mechanisms, Models, and

  2026-07-09

  This thought-leadership article explores how Docetaxel’s microtubule-stabilizing mechanism is shaping advanced cancer chemotherapy research, with a focus on complex tumor microenvironments and patient-derived assembloid models. We synthesize mechanistic insights, strategic guidance, and recent breakthroughs—highlighting APExBIO’s Docetaxel (SKU A4394)—to empower translational researchers in optimizing experimental design and bridging preclinical findings to clinical impact.

• Estradiol Modulates ER Stress to Restore CD4+ T Cells After

  2026-07-09

  The reference study demonstrates that 17β-estradiol counteracts hemorrhagic shock-induced immunosuppression by inhibiting endoplasmic reticulum stress in splenic CD4+ T lymphocytes. These findings clarify the mechanistic link between estrogen signaling, ER stress modulation, and T cell homeostasis, offering translational insights for immune restoration after trauma.

• (+)-Bicuculline: Practical Guide for GABAA Antagonist Workfl

  2026-07-08

  (+)-Bicuculline is a well-characterized GABAA receptor antagonist used to dissect inhibitory neurotransmission and study synaptic NMDA receptor signaling modulation in neuroscience research. It is not recommended for diagnostic, therapeutic, or clinical use, and reproducible results require careful adherence to preparation and storage protocols.

• KPT-330 (Selinexor): Applied Workflows and Troubleshooting i

  2026-07-08

  KPT-330 (Selinexor) is transforming experimental oncology by enabling precise, selective inhibition of CRM1-mediated nuclear export, resulting in robust apoptosis induction and tumor growth suppression. This guide translates cutting-edge findings and practical workflows into actionable strategies for maximizing Selinexor's impact in cancer research.

450 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page